Intrinsic Value of S&P & Nasdaq Contact Us

Becton, Dickinson and Company BDXB NYSE

NYSE • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
64/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — BDXB

Becton, Dickinson and Company (BDXB) has a market capitalization of $13.69B and trades at $48.16. The 52-week range is 45.85-52.52.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 8.2, Earnings Per Share (EPS) of $5.84, annual revenue of $21.84B.

The stock has a beta of 0.56, a last dividend of $3.0000, operates in the Healthcare sector.

Trading Data
Current Price$48.16
52-Week Range45.85-52.52
Volume2.76M
Avg Volume (30D)449.58K
Market Cap$13.69B
Beta (1Y)0.56
Last Dividend$3.0000
Company
IPO Date2020-05-21
Employees77,000
CEOThomas E. Polen Jr.
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS0758874061
CUSIP075887406
Income (Latest Year)
Revenue$21.84B
Gross Profit$9.92B
EBITDA$4.96B
Operating Income$2.58B
Net Income$1.68B
EPS$5.84
EPS Diluted$5.83
Shares Outstanding$286.61M
Balance Sheet (Latest Year)
Total Assets$55.33B
Current Assets$9.26B
Cash & ST Investments$859M
Total Liabilities$29.94B
Total Debt$19.18B
Net Debt$18.33B
Total Equity$25.39B
Debt / Equity0.76
Valuation Ratios
P/E Ratio8.2
P/S Ratio0.63
P/B Ratio0.54
EV/EBITDA (approx)2.8
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message